Gene Therapy in Cystic Fibrosis

Michelle Prickett*, Manu Jain

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene and is the most common life-shortening genetic defect in Caucasians. Life expectancy in CF has improved substantially during the past 75. years because of treatments aimed at end-organ complications. Since the CFTR gene was discovered in 1989, more than 1900 mutations have been reported to cause CF, and significant effort has been put forth into gene therapy to find a mutation-independent "cure" for CF. Gene-based approaches have not yet led to a viable therapy but have provided insights into hurdles that limit the efficacy and tolerability of gene therapy. This chapter will address the nomenclature of CFTR mutations, attempts at viral and nonviral gene therapy, and recent advances in mutation-specific protein repair molecules.

Original languageEnglish (US)
Title of host publicationTranslating Gene Therapy to the Clinic
Subtitle of host publicationTechniques and Approaches
PublisherElsevier Inc
Pages247-260
Number of pages14
ISBN (Electronic)9780128005644
ISBN (Print)9780128005637
DOIs
StatePublished - Nov 17 2014

Fingerprint

Gene therapy
Cystic Fibrosis
Genetic Therapy
Genes
Mutation
Regulator Genes
Terminology
Repair
Viral Genes
Defects
Life Expectancy
Molecules
Proteins
Therapeutics

Keywords

  • CFTR
  • Cystic fibrosis
  • Gene therapy
  • Mutation
  • Protein-repair

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Prickett, M., & Jain, M. (2014). Gene Therapy in Cystic Fibrosis. In Translating Gene Therapy to the Clinic: Techniques and Approaches (pp. 247-260). Elsevier Inc. https://doi.org/10.1016/B978-0-12-800563-7.00016-6
Prickett, Michelle ; Jain, Manu. / Gene Therapy in Cystic Fibrosis. Translating Gene Therapy to the Clinic: Techniques and Approaches. Elsevier Inc, 2014. pp. 247-260
@inbook{3a7af0376a4d4a4fb0a47c592641fd51,
title = "Gene Therapy in Cystic Fibrosis",
abstract = "Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene and is the most common life-shortening genetic defect in Caucasians. Life expectancy in CF has improved substantially during the past 75. years because of treatments aimed at end-organ complications. Since the CFTR gene was discovered in 1989, more than 1900 mutations have been reported to cause CF, and significant effort has been put forth into gene therapy to find a mutation-independent {"}cure{"} for CF. Gene-based approaches have not yet led to a viable therapy but have provided insights into hurdles that limit the efficacy and tolerability of gene therapy. This chapter will address the nomenclature of CFTR mutations, attempts at viral and nonviral gene therapy, and recent advances in mutation-specific protein repair molecules.",
keywords = "CFTR, Cystic fibrosis, Gene therapy, Mutation, Protein-repair",
author = "Michelle Prickett and Manu Jain",
year = "2014",
month = "11",
day = "17",
doi = "10.1016/B978-0-12-800563-7.00016-6",
language = "English (US)",
isbn = "9780128005637",
pages = "247--260",
booktitle = "Translating Gene Therapy to the Clinic",
publisher = "Elsevier Inc",

}

Prickett, M & Jain, M 2014, Gene Therapy in Cystic Fibrosis. in Translating Gene Therapy to the Clinic: Techniques and Approaches. Elsevier Inc, pp. 247-260. https://doi.org/10.1016/B978-0-12-800563-7.00016-6

Gene Therapy in Cystic Fibrosis. / Prickett, Michelle; Jain, Manu.

Translating Gene Therapy to the Clinic: Techniques and Approaches. Elsevier Inc, 2014. p. 247-260.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Gene Therapy in Cystic Fibrosis

AU - Prickett, Michelle

AU - Jain, Manu

PY - 2014/11/17

Y1 - 2014/11/17

N2 - Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene and is the most common life-shortening genetic defect in Caucasians. Life expectancy in CF has improved substantially during the past 75. years because of treatments aimed at end-organ complications. Since the CFTR gene was discovered in 1989, more than 1900 mutations have been reported to cause CF, and significant effort has been put forth into gene therapy to find a mutation-independent "cure" for CF. Gene-based approaches have not yet led to a viable therapy but have provided insights into hurdles that limit the efficacy and tolerability of gene therapy. This chapter will address the nomenclature of CFTR mutations, attempts at viral and nonviral gene therapy, and recent advances in mutation-specific protein repair molecules.

AB - Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene and is the most common life-shortening genetic defect in Caucasians. Life expectancy in CF has improved substantially during the past 75. years because of treatments aimed at end-organ complications. Since the CFTR gene was discovered in 1989, more than 1900 mutations have been reported to cause CF, and significant effort has been put forth into gene therapy to find a mutation-independent "cure" for CF. Gene-based approaches have not yet led to a viable therapy but have provided insights into hurdles that limit the efficacy and tolerability of gene therapy. This chapter will address the nomenclature of CFTR mutations, attempts at viral and nonviral gene therapy, and recent advances in mutation-specific protein repair molecules.

KW - CFTR

KW - Cystic fibrosis

KW - Gene therapy

KW - Mutation

KW - Protein-repair

UR - http://www.scopus.com/inward/record.url?scp=84944414789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944414789&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800563-7.00016-6

DO - 10.1016/B978-0-12-800563-7.00016-6

M3 - Chapter

SN - 9780128005637

SP - 247

EP - 260

BT - Translating Gene Therapy to the Clinic

PB - Elsevier Inc

ER -

Prickett M, Jain M. Gene Therapy in Cystic Fibrosis. In Translating Gene Therapy to the Clinic: Techniques and Approaches. Elsevier Inc. 2014. p. 247-260 https://doi.org/10.1016/B978-0-12-800563-7.00016-6